Search Results
Oct 09, 2025, 10:01 ET Cardiovascular Drugs Market to 2030: APAC Leads Growth and Telehealth Helps Online Pharmacies Expand, Says Mordor Intelligence
AbbVie Amgen Daiichi Sankyo Novo Nordisk GSK Takeda Abbott Laboratories Roche Servier
More news about: Mordor Intelligence Private Limited
Oct 08, 2025, 08:00 ET Visier Recognized as a Strategic Leader in 2025 Fosway 9-Grid™ for Cloud HR for the Third Consecutive Year
inclusive, equitable, and high-performing teams ready for the future of work. Leading enterprises across EMEA like Standard Bank, GSK, IQVIA, Merck, bpost, and more around the globe partner with Visier to embed data-driven decision-making into the flow of work and enhance HR's strategic
More news about: Visier
Oct 07, 2025, 08:37 ET Bring Your Own Technology (BYOT) Playbook Offers Roadmap for Using Site-Based Tools in Pharma-Sponsored Trials
reflects the expertise of workstream leads Brandon Maggio (GSK), Rick Greenfield (RealTime eClinical Solutions), and Joe Dustin (Dauntless eClinical Strategies), with contributions from members representing Medable, BMS, Syneos Health, Medidata, GSK, Eli Lilly; and advisors including Jane Myles (DTRA), David
More news about: RealTime eClinical Solutions
Oct 06, 2025, 16:01 ET PM360 2025 Trailblazer Awards Winners Announced: Top Companies, Marketers, CEOs, Products, and Initiatives Honored at Gala, Sept. 30th
Marketing Lead (MODERNA) Infectious Disease/Vaccine: Stacie Patterson, Director, Oncology Marketing (GSK) Innovation/Digital Strategy: Dave Giuga, Executive Director of Commercial Innovation (AstraZeneca)
More news about: PM360
Oct 01, 2025, 17:31 ET CXCR Inhibitors Market Set to Gain Momentum with Emerging Clinical Successes and Pipeline Expansion | DelveInsight
Company, Merck, Bristol-Myers Squibb, Roche, Shanghai Henlius Biotech, AbbVie, Daiichi Sankyo, Nuvation Bio, PDC*line Pharma, Moderna Therapeutics, Pfizer, GSK, Gilead Sciences, BieGene, Nuvalent, among others. About DelveInsight
More news about: DelveInsight Business Research, LLP
Oct 01, 2025, 06:40 ET Scleroderma Market to Reach US$ 4,103.07 Million by 2033 as Biologics, Targeted Therapies, and Early Diagnosis Transform Patient Outcomes | Report by DataM Intelligence
long-term lung function preservation, the company is expanding its market reach. GSK plc GSK is advancing biologics targeting immune and fibrotic pathways. Its ongoing collaborations with academic institutions
More news about: DataM Intelligence 4 Market Research LLP
Sep 30, 2025, 17:31 ET HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight
Therapeutics, Tizona Therapeutics, Totus Medicines, Turnstone Biologics, Hoffmann-La Roche, Hookipa Pharma, Zenith Epigenetics, HiFiBiO, Nanobiotix, GSK, AstraZeneca, Merus, PureTech Health, Rakuten Medical, Jacobio Pharmaceuticals, among others.
More news about: DelveInsight Business Research, LLP
Sep 29, 2025, 17:31 ET DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight
Malignant Pleural Mesothelioma, and others. Leading DNA synthesis inhibitor companies, such as AiCuris, Merck & Co., GSK, NuCana, ViiV Healthcare, Carna Biosciences, and others, are developing novel DNA synthesis inhibitors that can be available in the DNA synthesis
More news about: DelveInsight Business Research, LLP
Sep 29, 2025, 12:03 ET The National Cyber Security Agency (NCSA) - State of Qatar Partners with ISASecure to Accelerate Adoption of ISA/IEC 62443 Cybersecurity Standards
internationally recognized benchmarks for OT security. ISASecure's global ecosystem includes leaders such as Chevron, ExxonMobil, GSK, Saudi Aramco, Honeywell, Johnson Controls, Schneider Electric, Siemens, Trane Technologies and Yokogawa, among others. For more
More news about: The International Society of Automation
Sep 29, 2025, 08:09 ET Mosaic Consulting Expands Salesforce and Braze Services, Showcases Software Expertise with DrugAlert.ai
annuities and life insurance. Founded by Craig Mora, a former Director of Digital Solutions at Epsilon who supported GSK and AbbVie on global Salesforce initiatives, Mosaic has quickly become a trusted partner for businesses that need both deep technical expertise
More news about: Mosaic Consulting
Sep 28, 2025, 09:00 ET Altesa BioSciences Presents Findings Demonstrating Beneficial Effects of vapendavir for Treating Rhinovirus Infections in COPD Challenge Study
Commenting further on Prof. Johnston's findings, Dr. Katharine Knobil, Chief Medical Officer of Altesa and former Chief Medical Officer of GSK said, "his is the first study that has shown that an antiviral for rhinovirus infection, the most common cause of COPD exacerbations, can have a positive
More news about: Altesa Biosciences Inc.
Sep 25, 2025, 17:31 ET TL1A Binder Market Set to Expand by 2034 with Key Players Such as Merck, Roche, Teva Pharmaceuticals, Sanofi, and Others Driving Multi-Indication Advancements | DelveInsight
forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key systemic sclerosis companies, including Kyowa Kirin, GSK, AstraZeneca, Amgen (Horizon Therapeutics), Mitsubishi Tanabe Pharma, Roche (Genentech), Kiniksa Pharmaceuticals, Boehringer Ingelheim, aTyr Pharma,
More news about: DelveInsight Business Research, LLP
Sep 23, 2025, 10:01 ET With 5% CAGR Paracetamol Market is expected to grow US$15.03 billion by 2031, surging amid the Growing Pharmaceutical Industry | The Insight Partners
medications.Competitive Landscape and Major Developments Key Players: A few major companies operating in the market are Mallinckrodt Plc, GSK Plc, Johnson & Johnson, Sanofi SA, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd,
More news about: The Insight Partners
Sep 22, 2025, 17:31 ET Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along with rising prevalence | DelveInsight
barriers, and key JAK inhibitors companies, including Incyte Corporation, Aclaris Therapeutics, Sareum, Takeda, AstraZeneca, Ajax Therapeutics, Pfizer, GSK, Dizal Pharmaceutical, Confluence Life Sciences, Celon Pharma, Arcutis Biotherapeutics, Reistone Biopharma, among others.
More news about: DelveInsight Business Research, LLP
Sep 22, 2025, 11:13 ET Parkinson's Disease Therapeutics Market Size to Hit US$ 12.83 Billion by 2033, Report by DataM Intelligence
Roche Ltd., AbbVie Inc., Supernus Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC., Merck & Co., Inc., Boehringer Ingelheim International GmbH., GSK plc., Novartis AG, UCB S.A., Teva Pharmaceutical Industries Ltd., Acadia Pharmaceuticals Inc., Kyowa Kirin Co., Ltd., and Kyowa Kirin Co., Ltd. Purchase
More news about: DataM Intelligence 4 Market Research LLP
Sep 22, 2025, 10:08 ET Antibiotics Market Size to Surpass USD 55.26 Billion by 2033, Report by DataM Intelligence
pathways for critical antibiotics, further encouraging innovation. Moreover, leading pharmaceutical companies such as Novartis, Sanofi, Bayer, Basilea, and GSK are actively launching new antibiotics in the region. Combined with robust awareness and stewardship programs, these factors position Europe
More news about: DataM Intelligence 4 Market Research LLP
Sep 18, 2025, 13:47 ET Formation Bio Expands Leadership Team With Top Biotech and Pharma Executives to Accelerate AI-Driven Drug Development
represent decades of leadership at some of the most influential pharmaceutical and biotech companies — including Pfizer, BenevolentAI, Incyte, Janssen, GSK, and multiple innovative biotechs — and mark a major expansion of Formation Bio's leadership bench as it builds the pharmaceutical company of the future.
More news about: Formation Bio
Sep 18, 2025, 09:15 ET Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
our biopharma partners." Alnylam is the ninth member of the alliance, joining AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Merck, and Novo Nordisk. Alnylam's partnership will further strengthen the AGD clinical genomic database, enabling additional investment to sequence
More news about: Illumina, Inc.
Sep 16, 2025, 07:30 ET Yasir Al-Wakeel Appointed CEO of Vesalius Therapeutics and CEO-Partner of Flagship Pioneering
strategic alliance with GSK to discover and develop novel treatments for Parkinson's disease and an undisclosed neurodegenerative indication. Vesalius's internal development efforts
More news about: Flagship Pioneering
Sep 15, 2025, 08:31 ET Navigating the Knowledge Paradox: Why Having Some Answers can be Worse Than Having None by Yonsei University
application—combined with limited internal experience—led to a flawed product and market failure. In our paper, we further discuss how Merck, Sanofi, and GSK relied on their existing external knowledge on vaccine platforms for COVID-19, but these approaches turned out to be dead ends, causing them to abandon
More news about: Yonsei University